{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:17:10Z","timestamp":1773332230944,"version":"3.50.1"},"reference-count":65,"publisher":"China Science Publishing & Media Ltd.","issue":"8","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.3724\/abbs.2022094","type":"journal-article","created":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T06:49:01Z","timestamp":1657435741000},"page":"1080-1089","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis"],"prefix":"10.3724","volume":"54","author":[{"given":"Xiaoshuang","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jocd.2017.06.011","volume":"20","author":"Poiana C","year":"2017","unstructured":"Poiana C, Capatina C. Fracture risk assessment in patients with diabetes mellitus. J Clin Densitometry, 2017, 20: 432-443.","journal-title":"J Clin Densitometry"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00223-015-9954-z","volume":"96","author":"Shu L","year":"2015","unstructured":"Shu L, Beier E, Sheu T, Zhang H, Zuscik MJ, Puzas EJ, Boyce BF. High-fat diet causes bone loss in young mice by promoting osteoclastogenesis through alteration of the bone marrow environment. Calcif Tissue Int, 2015, 96: 313-323.","journal-title":"Calcif Tissue Int"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/JOE-14-0514","volume":"225","author":"Stabley JN","year":"2015","unstructured":"Stabley JN, Prisby RD, Behnke BJ, Delp MD. Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat. J Endocrinol, 2015, 225: 47-58.","journal-title":"J Endocrinol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mce.2015.01.001","volume":"410","author":"Lecka-Czernik B","year":"2015","unstructured":"Lecka-Czernik B, Stechschulte LA, Czernik PJ, Dowling AR. High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity. Mol Cell Endocrinol, 2015, 410: 35-41.","journal-title":"Mol Cell Endocrinol"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"e140214","DOI":"10.1172\/JCI140214","volume":"131","author":"Yu W","year":"2021","unstructured":"Yu W, Zhong L, Yao L, Wei Y, Gui T, Li Z, Kim H. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss. J Clin Investigation, 2021, 131:","journal-title":"J Clin Investigation"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"Teitelbaum SL","year":"2000","unstructured":"Teitelbaum SL. Bone resorption by osteoclasts. Science, 2000, 289: 1504-1508.","journal-title":"Science"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s00018-018-2817-9","volume":"75","author":"Park-Min KH","year":"2018","unstructured":"Park-Min KH. Mechanisms involved in normal and pathological osteoclastogenesis. Cell Mol Life Sci, 2018, 75: 2519-2528.","journal-title":"Cell Mol Life Sci"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/ijms18071345","volume":"18","author":"Stapleton M","year":"2017","unstructured":"Stapleton M, Sawamoto K, Alm\u00e9ciga-D\u00edaz CJ, Mackenzie WG, Mason RW, Orii T, Tomatsu S. Development of bone targeting drugs. Int J Mol Sci, 2017, 18:","journal-title":"Int J Mol Sci"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"Lacey DL","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 1998, 93: 165-176.","journal-title":"Cell"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"Kong YY","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature, 1999, 397: 315-323.","journal-title":"Nature"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"Li J","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA, 2000, 97: 1566-1571.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S8756-3282(01)00657-3","volume":"30","author":"Lee SE","year":"2002","unstructured":"Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone, 2002, 30: 71-77.","journal-title":"Bone"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1124\/mol.109.057877","volume":"77","author":"Lee JH","year":"2010","unstructured":"Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH. Epigallocatechin-3-gallate Inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-\u03baB signal. Mol Pharmacol, 2010, 77: 17-25.","journal-title":"Mol Pharmacol"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bcp.2014.10.019","volume":"93","author":"Wu C","year":"2015","unstructured":"Wu C, Wang W, Tian B, Liu X, Qu X, Zhai Z, Li H. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro. Biochem Pharmacol, 2015, 93: 59-71.","journal-title":"Biochem Pharmacol"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.phrs.2015.05.006","volume":"99","author":"Thummuri D","year":"2015","unstructured":"Thummuri D, Jeengar MK, Shrivastava S, Nemani H, Ramavat RN, Chaudhari P, Naidu VGM. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling. Pharmacol Res, 2015, 99: 63-73.","journal-title":"Pharmacol Res"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/art.34403","volume":"64","author":"Vattakuzhi Y","year":"2012","unstructured":"Vattakuzhi Y, Abraham SM, Freidin A, Clark AR, Horwood NJ. Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis. Arthritis Rheumatism, 2012, 64: 2201-2210.","journal-title":"Arthritis Rheumatism"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1007\/s00018-012-0983-8","volume":"69","author":"Thouverey C","year":"2012","unstructured":"Thouverey C, Caverzasio J. The p38\u03b1 MAPK positively regulates osteoblast function and postnatal bone acquisition. Cell Mol Life Sci, 2012, 69: 3115-3125.","journal-title":"Cell Mol Life Sci"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00109-017-1553-1","volume":"95","author":"Thummuri D","year":"2017","unstructured":"Thummuri D, Naidu VGM, Chaudhari P. Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-\u03baB and MAPK signalling. J Mol Med, 2017, 95: 1065-1076.","journal-title":"J Mol Med"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/01.rhu.0000231385.94784.e4","volume":"12","author":"Sigal LH","year":"2006","unstructured":"Sigal LH. Basic science for the clinician 39. J Clin Rheumatol, 2006, 12: 207-211.","journal-title":"J Clin Rheumatol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jep.2017.01.021","volume":"198","author":"Liu C","year":"2017","unstructured":"Liu C, Ma R, Wang L, Zhu R, Liu H, Guo Y, Zhao B. Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology. J EthnoPharmacol, 2017, 198: 351-362.","journal-title":"J EthnoPharmacol"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/rcm.5036","volume":"25","author":"Guo N","year":"2011","unstructured":"Guo N, Yu Y, Ablajan K, Li L, Fan B, Peng J, Yan H. Seasonal variations in metabolite profiling of the fruits of Ligustrum lucidum Ait. Rapid Commun Mass Spectrom, 2011, 25: 1701-1714.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/molecules21121756","volume":"21","author":"Wu J","year":"2016","unstructured":"Wu J, Ke X, Fu W, Gao X, Zhang H, Wang W, Ma N. Inhibition of hypoxia-induced retinal angiogenesis by specnuezhenide, an effective constituent of Ligustrum lucidum Ait., through suppression of the HIF-1\u03b1\/VEGF signaling pathway. Molecules, 2016, 21:","journal-title":"Molecules"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1055\/s-0029-1240869","volume":"76","author":"Fu G","year":"2010","unstructured":"Fu G, Ip FCF, Pang H, Ip NY. New secoiridoid glucosides from ligustrum lucidum induce ERK and CREB phosphorylation in cultured cortical neurons. Planta Med, 2010, 76: 998-1003.","journal-title":"Planta Med"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.14715\/cmb\/2019.66.1.10","volume":"66","author":"Yang J","year":"2020","unstructured":"Yang J, Jia J, Yang Y, Zhao Y, Li Q. Protective effect of Specnuezhenide on islet \u00ce\u00b2 cell of rats with gestational diabetes mellitus. Cell Mol Biol (Noisy-le-grand), 2020, 66: 60-64.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8054073","volume":"2018","author":"Wang-Fischer Y","year":"2018","unstructured":"Wang-Fischer Y, Garyantes T. Improving the reliability and utility of streptozotocin-induced rat diabetic model. J Diabetes Res, 2018, 2018: 1-14.","journal-title":"J Diabetes Res"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ame2.12023","volume":"1","author":"Zhao YQ","year":"2018","unstructured":"Zhao YQ, Liu YQ, Yuan JF, Dai X, Niu MM, Sun XM, Kuang DX. Regeneration of islet \u03b2-cells in tree shrews and rats. Animal Model Exp Med, 2018, 1: 152-161.","journal-title":"Animal Model Exp Med"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"e20180314","DOI":"10.1590\/0001-3765201920180314","volume":"91","author":"Magalh\u00e3es DAD","year":"2019","unstructured":"Magalh\u00e3es DAD, Kume WT, Correia FS, Queiroz TS, Allebrandt Neto EW, Santos MPD, Kawashita NH. High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: a new proposal. An Acad Bras Ci\u00eanc, 2019, 91:","journal-title":"An Acad Bras Ci\u00eanc"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.biopha.2017.08.098","volume":"95","author":"Gheibi S","year":"2017","unstructured":"Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin. Biomed Pharmaco Ther, 2017, 95: 605-613.","journal-title":"Biomed Pharmaco Ther"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s13770-018-0116-z","volume":"15","author":"Yoon JY","year":"2018","unstructured":"Yoon JY, Baek CW, Kim HJ, Kim EJ, Byeon GJ, Yoon JU. Remifentanil negatively regulates RANKL-induced osteoclast differentiation and bone resorption by inhibiting c-Fos\/NFATc1 expression. Tissue Eng Regen Med, 2018, 15: 333-340.","journal-title":"Tissue Eng Regen Med"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4049\/jimmunol.1002579","volume":"187","author":"Du J","year":"2011","unstructured":"Du J, Cheng B, Zhu X, Ling C. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects. J Immunol, 2011, 187: 942-950.","journal-title":"J Immunol"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1359\/jbmr.2003.18.12.2159","volume":"18","author":"Wang C","year":"2003","unstructured":"Wang C, Steer JH, Joyce DA, Yip KHM, Zheng MH, Xu J. 12- O-tetradecanoylphorbol-13-acetate (TPA) Inhibits Osteoclastogenesis by Suppressing RANKL-Induced NF-\u03baB Activation. J Bone Miner Res, 2003, 18: 2159-2168.","journal-title":"J Bone Miner Res"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00011-019-01228-w","volume":"68","author":"Wilches-Buitrago L","year":"2019","unstructured":"Wilches-Buitrago L, Viacava PR, Cunha FQ, Alves-Filho JC, Fukada SY. Fructose 1,6-bisphosphate inhibits osteoclastogenesis by attenuating RANKL-induced NF-\u03baB\/NFATc-1. Inflamm Res, 2019, 68: 415-421.","journal-title":"Inflamm Res"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"Takayanagi H","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell, 2002, 3: 889-901.","journal-title":"Dev Cell"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"14667","DOI":"10.1074\/jbc.M901670200","volume":"284","author":"Feng HT","year":"2009","unstructured":"Feng HT, Cheng T, Steer JH, Joyce DA, Pavlos NJ, Leong CL, Kular J. Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis. J Biol Chem, 2009, 284: 14667-14676.","journal-title":"J Biol Chem"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1749-6632.2003.tb03214.x","volume":"995","author":"Ortega N","year":"2003","unstructured":"Ortega N, Behonick D, Stickens D, Werb Z. How proteases regulate bone morphogenesis. Ann New York Acad Sci, 2003, 995: 109-116.","journal-title":"Ann New York Acad Sci"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0009-8981(99)00230-2","volume":"291","author":"Delaiss\u00e9 JM","year":"2000","unstructured":"Delaiss\u00e9 JM, Engsig MT, Everts V, del Carmen Ovejero M, Ferreras M, Lund L, Vu TH. Proteinases in bone resorption: obvious and less obvious roles. Clinica Chim Acta, 2000, 291: 223-234.","journal-title":"Clinica Chim Acta"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"Takayanagi H","year":"2007","unstructured":"Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol, 2007, 7: 292-304.","journal-title":"Nat Rev Immunol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"Asagiri M","year":"2007","unstructured":"Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone, 2007, 40: 251-264.","journal-title":"Bone"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/jcb.25763","volume":"118","author":"Choi JH","year":"2017","unstructured":"Choi JH, Han Y, Kim YA, Jin SW, Lee GH, Jeong HM, Lee HS. Platycodin D inhibits osteoclastogenesis by repressing the NFATc1 and MAPK signaling pathway. J Cell Biochem, 2017, 118: 860-868.","journal-title":"J Cell Biochem"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"118661","DOI":"10.1016\/j.lfs.2020.118661","volume":"264","author":"Kumar S","year":"2021","unstructured":"Kumar S, Behl T, Sachdeva M, Sehgal A, Kumari S, Kumar A, Kaur G. Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus. Life Sci, 2021, 264:","journal-title":"Life Sci"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9067610","volume":"2020","author":"Ma H","year":"2020","unstructured":"Ma H, Wang X, Zhang W, Li H, Zhao W, Sun J, Yang M. Melatonin suppresses ferroptosis induced by high glucose via activation of the Nrf2\/HO-1 signaling pathway in type 2 diabetic osteoporosis. Oxid Med Cell Longev, 2020, 2020: 1-18.","journal-title":"Oxid Med Cell Longev"},{"key":"CITATION42","doi-asserted-by":"crossref","unstructured":"Tafaro L, Napoli N. Current and Emerging Treatment of Osteoporosis. In: Falaschi P, Marsh D eds. Orthogeriatrics: The Management of Older Patients with Fragility Fractures Cham (CH): Springer Copyright 2021, The Author(s). 2021: 257\u2013272.","DOI":"10.1007\/978-3-030-48126-1_15"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/jcp.26084","volume":"233","author":"Song F","year":"2018","unstructured":"Song F, Wei C, Zhou L, Qin A, Yang M, Tickner J, Huang Y. Luteoloside prevents lipopolysaccharide\u2010induced osteolysis and suppresses RANKL\u2010induced osteoclastogenesis through attenuating RANKL signaling cascades. J Cell Physiol, 2018, 233: 1723-1735.","journal-title":"J Cell Physiol"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.bcp.2010.04.014","volume":"80","author":"Lee JW","year":"2010","unstructured":"Lee JW, Kobayashi Y, Nakamichi Y, Udagawa N, Takahashi N, Im NK, Seo HJ. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice. Biochem Pharmacol, 2010, 80: 352-361.","journal-title":"Biochem Pharmacol"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"27470","DOI":"10.3390\/ijms161126039","volume":"16","author":"Wang T","year":"2015","unstructured":"Wang T, Liu Q, Zhou L, Yuan JB, Lin X, Zeng R, Liang X. Andrographolide inhibits ovariectomy-induced bone loss via the suppression of RANKL signaling pathways. Int J Mol Sci, 2015, 16: 27470-27481.","journal-title":"Int J Mol Sci"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"e89159","DOI":"10.1371\/journal.pone.0089159","volume":"9","author":"Chiou WF","year":"2014","unstructured":"Chiou WF, Huang YL, Liu YW. (+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activation. PLoS ONE, 2014, 9:","journal-title":"PLoS ONE"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1472-6882-14-35","volume":"14","author":"Choi SW","year":"2014","unstructured":"Choi SW, Park KI, Yeon JT, Ryu BJ, Kim KJ, Kim SH. Anti-osteoclastogenic activity of matairesinol via suppression of p38\/ERK-NFATc1 signaling axis. BMC Complement Altern Med, 2014, 14:","journal-title":"BMC Complement Altern Med"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.bcp.2013.09.009","volume":"86","author":"Satu\u00e9 M","year":"2013","unstructured":"Satu\u00e9 M, Arriero MM, Monjo M, Ramis JM. Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells. Biochem Pharmacol, 2013, 86: 1476-1486.","journal-title":"Biochem Pharmacol"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1359\/jbmr.081115","volume":"24","author":"Kawaguchi H","year":"2009","unstructured":"Kawaguchi H. Regulation of osteoarthritis development by wnt\u2013\u03b2-catenin signaling through the endochondral ossification process. J Bone Mineral Res, 2009, 24: 8-11.","journal-title":"J Bone Mineral Res"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/ijms18010133","volume":"18","author":"Cheleschi S","year":"2017","unstructured":"Cheleschi S, De Palma A, Pecorelli A, Pascarelli NA, Valacchi G, Belmonte G, Carta S. Hydrostatic pressure regulates microRNA expression levels in osteoarthritic chondrocyte cultures via the Wnt\/\u03b2-Catenin pathway. Int J Mol Sci, 2017, 18:","journal-title":"Int J Mol Sci"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3389\/fphar.2018.00700","volume":"9","author":"Ma C","year":"2018","unstructured":"Ma C, Zhou X, Xu K, Wang L, Yang Y, Wang W, Liu A. Specnuezhenide decreases interleukin-1\u03b2-induced inflammation in rat chondrocytes and reduces joint destruction in osteoarthritic rats. Front Pharmacol, 2018, 9:","journal-title":"Front Pharmacol"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/biof.1241","volume":"41","author":"Deepak V","year":"2015","unstructured":"Deepak V, Kruger MC, Joubert A, Coetzee M. Piperine alleviates osteoclast formation through the p38\/c-Fos\/NFATc1 signaling axis. BioFactors, 2015, 41: 403-413.","journal-title":"BioFactors"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3892\/ijmm.2019.4269","volume":"44","author":"Kim JH","year":"2019","unstructured":"Kim JH, Kim M, Jung HS, Sohn Y. Leonurus sibiricus L. ethanol extract promotes osteoblast differentiation and inhibits osteoclast formation. Int J Mol Med, 2019, 44:","journal-title":"Int J Mol Med"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"153397","DOI":"10.1016\/j.phymed.2020.153397","volume":"80","author":"Kim MH","year":"2021","unstructured":"Kim MH, Lee H, Ha IJ, Yang WM. Zanthoxylum piperitum alleviates the bone loss in osteoporosis via inhibition of RANKL-induced c-fos\/NFATc1\/NF-\u03baB pathway. Phytomedicine, 2021, 80:","journal-title":"Phytomedicine"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1242\/jcs.00082","volume":"115","author":"David JP","year":"2002","unstructured":"David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci, 2002, 115: 4317-4325.","journal-title":"J Cell Sci"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S8756-3282(99)00105-2","volume":"25","author":"Boyce BF","year":"1999","unstructured":"Boyce BF, Xing L, Franzoso G, Siebenlist U. Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone, 1999, 25: 137-139.","journal-title":"Bone"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biochi.2018.11.008","volume":"157","author":"Yun J","year":"2019","unstructured":"Yun J, Lee KY, Park B. Neotuberostemonine inhibits osteoclastogenesis via blockade of NF-\u03baB pathway. Biochimie, 2019, 157: 81-91.","journal-title":"Biochimie"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"21706","DOI":"10.18632\/aging.103976","volume":"12","author":"Xiao L","year":"2020","unstructured":"Xiao L, Zhong M, Huang Y, Zhu J, Tang W, Li D, Shi J. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6\/ROS-dependent MAPK\/NF-\u03baB signaling pathways. Aging, 2020, 12: 21706-21729.","journal-title":"Aging"},{"key":"CITATION59","doi-asserted-by":"crossref","unstructured":"Mulero MC, Huxford T, Ghosh G. NF-\u03baB, I\u03baB, and IKK: Integral components of immune system signaling. Adv Exp Med Biol 2019, 1172: 207\u2013226.","DOI":"10.1007\/978-981-13-9367-9_10"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/jbmr.2771","volume":"31","author":"Zhou L","year":"2016","unstructured":"Zhou L, Liu Q, Yang M, Wang T, Yao J, Cheng J, Yuan J. Dihydroartemisinin, an anti-malaria drug, suppresses estrogen deficiency-induced osteoporosis, osteoclast formation, and RANKL-induced signaling pathways. J Bone Miner Res, 2016, 31: 964-974.","journal-title":"J Bone Miner Res"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"27087","DOI":"10.3390\/ijms161125998","volume":"16","author":"Zhou L","year":"2015","unstructured":"Zhou L, Song F, Liu Q, Yang M, Zhao J, Tan R, Xu J. Berberine sulfate attenuates osteoclast differentiation through RANKL induced NF-\u03baB and NFAT pathways. Int J Mol Sci, 2015, 16: 27087-27096.","journal-title":"Int J Mol Sci"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1177\/0022034518820289","volume":"98","author":"Taira TM","year":"2019","unstructured":"Taira TM, Lima V, Prado DS, Silva TA, Issa JPM, da Silva LAB, Zamboni DS. NLRP12 attenuates inflammatory bone loss in experimental apical periodontitis. J Dent Res, 2019, 98: 476-484.","journal-title":"J Dent Res"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"110060","DOI":"10.1016\/j.cellsig.2021.110060","volume":"85","author":"Fang C","year":"2021","unstructured":"Fang C, He M, Li D, Xu Q. YTHDF2 mediates LPS-induced osteoclastogenesis and inflammatory response via the NF-\u03baB and MAPK signaling pathways. Cell Signalling, 2021, 85:","journal-title":"Cell Signalling"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018027009","volume":"37","author":"Decean HP","year":"2018","unstructured":"Decean HP, Brie IC, Tatomir CB, Perde-Schrepler M, Fischer-Fodor E, Virag P. Targeting MAPK (p38, ERK, JNK) and inflammatory CK (GDF-15, GM-CSF) in UVB-Activated Human Skin Cells with Vitis vinifera Seed Extract. J Environ Pathol Toxicol Oncol, 2018, 37: 261-272.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbrc.2009.08.080","volume":"389","author":"Chang JH","year":"2009","unstructured":"Chang JH, Chang EJ, Kim HH, Kim SK. Enhanced inhibitory effects of a novel CpG motif on osteoclast differentiation via TREM-2 down-regulation. Biochem Biophys Res Commun, 2009, 389: 28-33.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/32B2D5E5FDED4F2CB6C386EA250FD615","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022094","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/32B2D5E5FDED4F2CB6C386EA250FD615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T03:23:10Z","timestamp":1663039390000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,4]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2022094","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}